BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28262043)

  • 1. Phosphorus-rich structures and capsular architecture in Cryptococcus neoformans.
    Ramos CL; Gomes FM; Girard-Dias W; Almeida FP; Albuquerque PC; Kretschmer M; Kronstad JW; Frases S; de Souza W; Rodrigues ML; Miranda K
    Future Microbiol; 2017 Mar; 12():227-238. PubMed ID: 28262043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.
    Maxson ME; Dadachova E; Casadevall A; Zaragoza O
    Eukaryot Cell; 2007 Jan; 6(1):95-109. PubMed ID: 17114596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.
    Zaragoza O; Telzak A; Bryan RA; Dadachova E; Casadevall A
    Mol Microbiol; 2006 Jan; 59(1):67-83. PubMed ID: 16359319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans capsular polysaccharides form branched and complex filamentous networks viewed by high-resolution microscopy.
    Araújo GR; Fontes GN; Leão D; Rocha GM; Pontes B; Sant'Anna C; de Souza W; Frases S
    J Struct Biol; 2016 Jan; 193(1):75-82. PubMed ID: 26655746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
    Cleare W; Casadevall A
    Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans.
    Fonseca FL; Nimrichter L; Cordero RJ; Frases S; Rodrigues J; Goldman DL; Andruszkiewicz R; Milewski S; Travassos LR; Casadevall A; Rodrigues ML
    Eukaryot Cell; 2009 Oct; 8(10):1543-53. PubMed ID: 19617395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
    Araujo Gde S; Fonseca FL; Pontes B; Torres A; Cordero RJ; Zancopé-Oliveira RM; Casadevall A; Viana NB; Nimrichter L; Rodrigues ML; Garcia ES; Souza Wd; Frases S
    PLoS One; 2012; 7(1):e29561. PubMed ID: 22253734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.
    Bryan RA; Zaragoza O; Zhang T; Ortiz G; Casadevall A; Dadachova E
    Eukaryot Cell; 2005 Feb; 4(2):465-75. PubMed ID: 15701808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans.
    Chang YC; Jong A; Huang S; Zerfas P; Kwon-Chung KJ
    Infect Immun; 2006 Jul; 74(7):3930-8. PubMed ID: 16790766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron cytochemical studies of Cryptococcus neoformans grown on uric acid and related sources of nitrogen.
    Fiskin AM; Zalles MC; Garrison RG
    J Med Vet Mycol; 1990; 28(3):197-207. PubMed ID: 2213435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulty in diagnosing chronic meningitis caused by capsule-deficient Cryptococcus neoformans.
    Sugiura Y; Homma M; Yamamoto T
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1460-1. PubMed ID: 16170098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of acetylsalicylic acid on oxylipin migration in Cryptococcus neoformans var. neoformans UOFS Y-1378.
    Sebolai OM; Pohl CH; Botes PJ; van Wyk PW; Kock JL
    Can J Microbiol; 2008 Feb; 54(2):91-6. PubMed ID: 18388977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
    Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML
    Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.
    Yauch LE; Mansour MK; Levitz SM
    Infect Immun; 2005 Dec; 73(12):8429-32. PubMed ID: 16299344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The capsular dynamics of Cryptococcus neoformans.
    McFadden D; Zaragoza O; Casadevall A
    Trends Microbiol; 2006 Nov; 14(11):497-505. PubMed ID: 16996739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron Microscopy of Cryptococcus neoformans: Processing Challenges to Avoid Artifacts.
    Araújo GRS; Pontes B; Frases S
    Methods Mol Biol; 2024; 2775():141-153. PubMed ID: 38758316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.
    Rodrigues ML; Nimrichter L; Oliveira DL; Frases S; Miranda K; Zaragoza O; Alvarez M; Nakouzi A; Feldmesser M; Casadevall A
    Eukaryot Cell; 2007 Jan; 6(1):48-59. PubMed ID: 17114598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial and temporal sequence of capsule construction in Cryptococcus neoformans.
    Pierini LM; Doering TL
    Mol Microbiol; 2001 Jul; 41(1):105-15. PubMed ID: 11454204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule.
    Nicola AM; Frases S; Casadevall A
    Eukaryot Cell; 2009 Sep; 8(9):1373-80. PubMed ID: 19465562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative method to prepare samples of the pathogenic yeast Cryptococcus neoformans for scanning electron microscopy analysis.
    Faganello J; Arruda W; Schrank A; Vainstein MH
    J Microbiol Methods; 2006 Mar; 64(3):416-9. PubMed ID: 16054253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.